Navigation Links
Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohn's Disease
Date:5/20/2008

ients who had relapsed during PRECiSE 2 but were treated with one additional dose of Cimzia(R) (PRECiSE 4), achieved and maintained remission at six and 12 months with maintenance dosing every 4 weeks and no dose escalation. [Abstract #T1133]

"The DDW meeting marks an exciting time to announce additional long-term data for Cimzia(R), given its recent approval by the FDA," said Olav Hellebo, Senior Vice President and President of Inflammation Operations, UCB. "UCB remains committed to providing healthcare professionals with effective therapies to improve the lives of patients suffering from this debilitating disease.

In a related analysis of PRECiSE 2 and 3, the durability of long-term maintenance of response and remission proved not to be related to the rapidity or magnitude of response or remission following induction of Cimzia(R), demonstrating that patients can go on to experience positive response and remission rates regardless of the magnitude and speed of the initial response. [Abstract #T1126]

The pooled data also shows that the PRECiSE Phase 2 and Phase 3 clinical trials showed no unexpected safety findings and no increase in the rate of common adverse events with sustained exposure to Cimzia(R). Results also demonstrate stable dosing in patients taking the medication for more than six months. [Abstract #469]

About the PRECiSE Clinical Trial Program

PRECiSE, one of the largest, most comprehensive development programs for an anti-TNF for Crohn's disease is composed of two placebo-controlled studies and two open-label safety follow-up studies. In 2007, the two former studies were published in the New England Journal of Medicine (NEJM). The studies demonstrated that patients with moderate to severe Crohn's disease achieved and sustained clinical response with Cimzia(R) for up to six months, compared to placebo. The safety and tolerability of Cimzia(R) was consistent with that expected of an anti-TNF agent. In the first follow-
'/>"/>

SOURCE UCB
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year
2. Concomitant Treatment With Nebulized Formoterol Fumarate and Tiotropium Provides Clinically Significant Improvements for COPD Patients
3. Concomitant Use of Nebulized Formoterol Fumarate and Tiotropium Provides Significant Improvement in Dyspnea, COPD Symptoms and Rescue Medication Use over Tiotropium Alone
4. New Lacosamide Data Provides Evidence for Long-Term Efficacy in Diabetic Neuropathic Pain
5. Cadence Pharmaceuticals Reports First Quarter 2008 Financial Results and Provides Clinical Program Update
6. Insmed Provides Update on Follow-On Biologics and IPLEX(TM) Programs
7. Gene Therapy Provides Vision to People who Were Nearly Blind
8. Arpida Provides Further Comments on the Pivotal Phase III Trials
9. Three Dimensional Visualization of Right Ventricle Provides Important Information for Treatment of Patients with Tetralogy of Fallot, According to a Study in The American Journal of Cardiology
10. InterMune Provides Additional Information on ITMN-191 (R7227) MAD Study Results
11. InterMune Announces Top-Line Results of Phase 1b Trial of ITMN-191 (R7227) and Provides Program Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... As health officials across the Midwest warn against the widespread ... Michigan will offer free diagnostic testing for ... to administer tests and, in some cases, fill the matching ... the study. The Grand Rapids, Mich. ...
(Date:1/15/2014)... Texas , Jan. 15, 2014  Novation, the leading ... awarded several new IT value-added reseller (VAR) national contracts ... IT goods and services at lower costs. These include ... services such as initiative assistance and ongoing IT consulting ...
(Date:1/15/2014)... Calif. , Jan. 15, 2014 Massachusetts ... (NASDAQ: AMGN ) announced today that ... discover and validate new therapeutic targets and develop ... chronic disorder that affects millions worldwide. The MGH-Broad-Amgen ...
Breaking Medicine Technology:Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 2Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 3New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4
... GlySure Limited, developer of in-hospital continuous blood glucose ... million Series C financing round. GlySure will use this ... the United States and Europe. The financing ... existing investors Amadeus Capital Partners, Chester Investments and Delta ...
... 9, 2012  Stemline Therapeutics, Inc., a clinical stage biopharmaceutical ... cells (CSCs), today announced that Eric K. Rowinsky, M.D. ... Medical Officer and Head of Research and Development. Dr. ... the Company,s two clinical stage drug candidates, SL-401 and ...
Cached Medicine Technology:GlySure Secures $10.9 Million in Series C Financing Round 2Stemline Therapeutics, Inc. Names Eric K. Rowinsky, M.D. Chief Medical Officer and Head of Research and Development 2Stemline Therapeutics, Inc. Names Eric K. Rowinsky, M.D. Chief Medical Officer and Head of Research and Development 3
(Date:7/12/2014)... The Chicken Egg Production ... years, buoyed by stable demand for industry products as ... are a relatively affordable staple for most families across ... grows in line with the size of the population,” ... for new specialty egg products with enriched qualities, such ...
(Date:7/12/2014)... The rise in the number of ... advanced network architectures to suit the upsurge. Virtualization has ... increasing cloud storage technologies. The data traffic has increased ... devices. This has resulted in larger and more complex ... for the SDN market. , The North American (NA) ...
(Date:7/12/2014)... The "North American ... Market by Angioplasty Balloon (Plain/Old, Cutting), ... IVC Filter (Retrievable), Endovascular Stent Graft ... studies the major market drivers, restraints, ... Canada. , Browse 108 market data ...
(Date:7/12/2014)... The Security Analytics market is estimated to grow from ... at an expected CAGR of 9.7% for the period ... increasing number of security breaches, continued line of sophisticated ... organizations are enormous. Vendors in the security analytics market ... develop better and more secure systems. , There has ...
(Date:7/12/2014)... Casinos in Australia have grown over ... and online casinos. Revenue is estimated to increase at ... 2014-15. Greater per capita gambling expenditure has assisted financial ... discretionary income levels have also assisted revenue growth, as ... as casino gambling services. Revenue is estimated to grow ...
Breaking Medicine News(10 mins):Health News:Chicken Egg Production in Canada Industry Market Research Report Now Available from IBISWorld 2Health News:Chicken Egg Production in Canada Industry Market Research Report Now Available from IBISWorld 3Health News:North America Software Defined Network (SDN) Market Worth $1,443.8 Million by 2019 - New Report by MicroMarket Monitor 2Health News:North America Software Defined Network (SDN) Market Worth $1,443.8 Million by 2019 - New Report by MicroMarket Monitor 3Health News:North America Software Defined Network (SDN) Market Worth $1,443.8 Million by 2019 - New Report by MicroMarket Monitor 4Health News:North America Software Defined Network (SDN) Market Worth $1,443.8 Million by 2019 - New Report by MicroMarket Monitor 5Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 2Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 3Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 4Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 5Health News:North America Security Analytics Market Worth $1,215.2 Million by 2019 - New Report by MicroMarket Monitor 2Health News:North America Security Analytics Market Worth $1,215.2 Million by 2019 - New Report by MicroMarket Monitor 3Health News:North America Security Analytics Market Worth $1,215.2 Million by 2019 - New Report by MicroMarket Monitor 4Health News:Casinos in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Casinos in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:Casinos in Australia Industry Market Research Report Now Updated by IBISWorld 4
... identify possible genetic links, but urge further study , ... genomic regions that might be associated with autism have ... researchers identified a single-letter change on chromosome 5 near ... help guide the growth of neurons and their long ...
... Oct. 7 Crawford & Company,s (NYSE: CRDA ... be offered under the brand name of Broadspire, a ... European market. , Crawford (NYSE: CRDA ; CRDB), ... announced this latest expansion of the Broadspire brand at ...
... RATON, Fla., Oct. 7 Coverall Health-Based Cleaning System(SM), a ... has been recognized as one of the "50 Top ... (NMFI) for the third year in a row. The ... section of USA Today, the national daily newspaper. Coverall ...
... Medicine (BUSM) have identified genes which may influence the onset ... on-line in BMC Medical Genetics , are the first ... and may help identify mechanisms and therapeutic targets capable of ... most common neurodegenerative disorder usually occurring late in life. ...
... HHS secretary says shots are made in same way as ... , WEDNESDAY, Oct. 7 (HealthDay News) -- U.S. Health and ... Americans -- especially those in high-risk groups -- to get ... and secure." , Appearing on the morning TV news programs, ...
... Charities USA (CCUSA) announced today that it is deploying ... to assist its Catholic Social Services agency in Pago ... providing relief and support services to the growing number ... (Logo: http://www.newscom.com/cgi-bin/prnh/20081008/CCUSALOGO ) , "The ...
Cached Medicine News:Health News:Potential Pieces of Autism Puzzle Revealed 2Health News:Crawford & Company's Broadspire Unit Continues Its European Expansion 2Health News:Coverall Named Among '50 Top Franchises for Minorities' for Third Consecutive Year 2Health News:Researchers identify genes associated with onset age of Parkinson's disease 2Health News:Sebelius Urges Americans to Get Swine Flu Vaccine 2Health News:Sebelius Urges Americans to Get Swine Flu Vaccine 3Health News:Catholic Charities USA Moves Disaster Response Team to American Samoa 2
... Siremobil Iso-C3D C-Arm imaging system interface sets ... mobile C-arm imaging. Combining mobility and ... the cooperative technologies deliver the most complete ... imaging is the new standard in the ...
... OmniSight image guided surgery system offers ... in design and use. It provides ... to localize critical anatomy and plan ... gives surgeons an easy-to-use, technologically advanced ...
... the next evolution in transforaminal lumbar interbody ... instruments.. The T.L.I.F. SG Instruments feature a ... preparation instruments designed to support the technically ... range of instrument options to meet the ...
The ZEPHIR Anterior Cervical Plate System is the lowest profile plate clinically available....
Medicine Products: